Sale!

ITGA7 Gene Myopathy due to Integrin 7A Deficiency Genetic Test

Original price was: $700.Current price is: $500.

-29%

The ITGA7 Gene Myopathy due to Integrin 7A Deficiency NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the ITGA7 gene responsible for congenital muscular dystrophy. This comprehensive next-generation sequencing test provides precise detection of genetic abnormalities causing progressive muscle weakness and developmental delays. Priced at $500 USD, the test offers crucial diagnostic clarity for patients experiencing unexplained muscle weakness, delayed motor milestones, or family history of neuromuscular disorders. Results are available within 3-4 weeks, enabling timely intervention and personalized treatment strategies for improved patient outcomes.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

ITGA7 Gene Myopathy due to Integrin 7A Deficiency NGS Genetic DNA Test

Comprehensive Genetic Testing for Muscular Dystrophy

The ITGA7 Gene Myopathy due to Integrin 7A Deficiency NGS Genetic DNA Test represents a breakthrough in neuromuscular disorder diagnostics. This advanced genetic test utilizes next-generation sequencing technology to identify mutations in the ITGA7 gene, which encodes the alpha-7 integrin protein crucial for muscle fiber integrity and function. Integrin 7A deficiency leads to congenital muscular dystrophy, a progressive condition affecting muscle strength and mobility from early childhood.

What This Test Measures and Detects

Our comprehensive NGS analysis targets the complete coding region of the ITGA7 gene, including:

  • Detection of point mutations, insertions, and deletions in the ITGA7 gene
  • Identification of pathogenic variants affecting integrin alpha-7 protein function
  • Analysis of genetic markers associated with congenital muscular dystrophy
  • Assessment of inheritance patterns (autosomal recessive)
  • Evaluation of mutation impact on muscle membrane stability

Who Should Consider This Genetic Test

This specialized genetic test is recommended for individuals presenting with:

  • Progressive muscle weakness beginning in infancy or early childhood
  • Delayed motor milestones and developmental delays
  • Family history of congenital muscular dystrophy or neuromuscular disorders
  • Unexplained muscle fatigue and reduced physical endurance
  • Joint contractures and limited range of motion
  • Respiratory complications related to muscle weakness
  • Abnormal muscle biopsy findings suggestive of integrin deficiency

Significant Benefits of ITGA7 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages:

  • Accurate Diagnosis: Confirms or rules out ITGA7-related myopathy with high precision
  • Early Intervention: Enables timely implementation of appropriate therapies and management strategies
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Personalized Treatment: Guides development of targeted treatment approaches based on genetic findings
  • Prognostic Information: Helps predict disease progression and potential complications
  • Research Contribution: Advances understanding of rare neuromuscular disorders

Understanding Your Test Results

Our comprehensive genetic report provides clear interpretation of your results:

  • Positive Result: Indicates the presence of pathogenic ITGA7 gene mutations confirming Integrin 7A deficiency diagnosis
  • Negative Result: Suggests ITGA7 gene mutations are not detected, though other genetic causes should be considered
  • Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation
  • Carrier Status: Determines if individuals carry one copy of mutated gene without disease symptoms

All results include detailed explanations and recommendations for follow-up care with qualified neurologists and genetic counselors.

Test Pricing and Details

Test Feature Details
Test Name ITGA7 Gene Myopathy due to Integrin 7A Deficiency NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and many more. Our network of certified collection centers ensures accessible genetic testing services nationwide.

Pre-Test Requirements and Preparation

To ensure optimal testing accuracy, we require:

  • Complete clinical history documentation of the patient
  • Genetic counseling session to create detailed family pedigree chart
  • Informed consent for genetic testing
  • Insurance pre-authorization when applicable

Take Control of Your Neurological Health Today

Don’t let uncertainty about muscle weakness or developmental delays continue. Our ITGA7 Gene Myopathy NGS Genetic DNA Test provides the answers you need for proper diagnosis and treatment planning. With our discounted price of $500 USD and comprehensive nationwide coverage, accessing advanced genetic testing has never been more convenient.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your ITGA7 Gene Myopathy test. Our dedicated genetic specialists are ready to guide you through the testing process and help you understand your results for better health outcomes.